Adults with type 1 or type 2 diabetes who used a continuous glucose monitor experienced fewer emergency department and ...

Dear Dr. Roach: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have ...

In a country where millions battle diabetes, the push for continuous glucose monitors has never been more critical. As ...

Abbott's Libre Assist will help individuals with diabetes better understand how their food choices may affect their glucose ...

Ultrahuman, best known for its smart rings, has launched its continuous glucose monitor in the US. The device was first released in the UK in June 2021. The Ultrahuman M1 CGM can be purchased with a ...

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...

Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...

Concerning’ disparities in access to continuous glucose monitors despite black and south Asian people being more likely to live with condition ...

Diabetes management has undergone a paradigm shift with the advent of continuous glucose monitoring (CGM) systems. These devices provide near real‐time insights into the dynamic fluctuations of blood ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...

Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre ...

Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.